| 1 |
33767348 | Reciprocal control of obesity and anxiety-depressive disorder via a GABA and serotonin neural circuit. | 2021 Jul |
1 |
| 2 |
30797147 | Potential roles of 5-HT3 receptor (5-HT3R) antagonists in modulating the effects of nicotine. | 2019 Apr |
1 |
| 3 |
29972203 | Impact of free Nε-carboxymethyllysine, its precursor glyoxal and AGE-modified BSA on serotonin release from human parietal cells in culture. | 2018 Jul 17 |
1 |
| 4 |
26576669 | Potential serotonergic agents for the treatment of schizophrenia. | 2016 |
1 |
| 5 |
20724042 | Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors. | 2010 Nov |
2 |
| 6 |
11762972 | Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study. | 2001 Nov |
1 |
| 7 |
8991800 | Effects of granisetron, a 5-HT3 receptor antagonist, on morphine-induced potentiation of brain stimulation reward. | 1995 Dec 20 |
1 |
| 8 |
7919451 | Clinical experience with intravenous granisetron. | 1994 Jun |
2 |
| 9 |
8032707 | Control of emesis by intravenous granisetron in breast cancer patients treated with 5-FU, epirubicin and cyclophosphamide. | 1994 May |
1 |